We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DORZTIMOLOL, DORZALAMIDE TIMOL, DORZAL TIMO, DORZALAM TIMOLOL (Neo Health (Australia) Pty Ltd)
Product name
DORZTIMOLOL, DORZALAMIDE TIMOL, DORZAL TIMO, DORZALAM TIMOLOL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
130 working days (255)
Active ingredients
Dorzolamide hydrochloride; Timolol maleate
Registration type
New generic medicine
Indication
DORZTIMOLOL, DORZALAMIDE TIMOL, DORZAL TIMO, DORZALAM TIMOLOL (eye drops) is indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.